Obstetrics & Gynecology Ultrasound Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Portability (Cart/Trolley-Based, Portable/Handheld), By Product (2D Ultrasound, 3D/4D Ultrasound, Doppler Ultrasound), By End Use (Hospitals, Diagnostic Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 2.21 Billion
CAGR (2026-2031)	5.17%
Fastest Growing Segment	Doppler Ultrasound
Largest Market	North America
Market Size (2031)	USD 2.99 Billion

Market Overview

The Global Obstetrics & Gynecology Ultrasound Devices Market will grow from USD 2.21 Billion in 2025 to USD 2.99 Billion by 2031 at a 5.17% CAGR. Obstetrics and gynecology ultrasound devices are specialized diagnostic imaging systems that utilize high-frequency sound waves to visualize the female reproductive tract and monitor fetal development. The global market is primarily driven by the increasing prevalence of gynecological disorders, such as uterine fibroids and ovarian cysts, alongside a rising frequency of high-risk pregnancies associated with advanced maternal age. Furthermore, the growing necessity for early disease detection and regular prenatal monitoring continues to stimulate the demand for these essential clinical tools, distinct from technological shifts like AI integration.

However, a significant challenge hindering market expansion is the global shortage of skilled sonographers and radiologists, which creates bottlenecks in diagnostic workflows. This workforce deficit restricts the capacity of healthcare facilities to manage the growing volume of required scans. For instance, according to the American Cancer Society, in 2025, approximately 20,890 women in the United States are projected to receive a new diagnosis of ovarian cancer, underscoring the critical and escalating need for accessible ultrasound diagnostic services to manage this disease burden.

Key Market Drivers

Advancements in 3D/4D imaging and Artificial Intelligence (AI) integration are fundamentally reshaping the Global Obstetrics & Gynecology Ultrasound Devices Market by enhancing diagnostic precision and clinical efficiency. Manufacturers are increasingly embedding machine learning algorithms to automate routine fetal measurements, thereby addressing critical workforce bottlenecks. For instance, according to GE HealthCare, April 2024, in the 'GE HealthCare Launches Voluson Signature Ultrasound Systems' press release, the company's new AI-enabled SonoLyst tool can reduce the time required to complete standard International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) second-trimester exams by up to 40%. This technological shift has spurred significant industry consolidation and investment; according to MobiHealthNews, May 2024, in the article 'Samsung Medison buying French ultrasound AI startup for $92M', Samsung Medison agreed to acquire the fetal ultrasound AI company Sonio for approximately $92 million to bolster its diagnostic software capabilities.

Simultaneously, the rising prevalence of gynecological and obstetric conditions acts as a primary catalyst for market growth, necessitating frequent and accurate imaging interventions. The escalating burden of malignancies and chronic reproductive health issues drives a continuous requirement for high-resolution diagnostic modalities to ensure timely interventions. According to the American Cancer Society, January 2024, in the 'Cancer Statistics, 2024' report, mortality rates for uterine corpus cancer are currently increasing by 2% per year, a trend that intensifies the clinical dependency on advanced ultrasound systems for early detection and treatment monitoring. This epidemiological pressure ensures a sustained demand for specialized imaging equipment capable of managing complex pathologies, distinct from the demand generated by routine obstetric care.

Download Free Sample Report

Key Market Challenges

The global shortage of skilled sonographers and radiologists constitutes a formidable barrier to the expansion of the Obstetrics and Gynecology Ultrasound Devices Market. As healthcare facilities face a widening gap between the demand for diagnostic imaging and the availability of qualified personnel to perform scans, significant operational bottlenecks emerge. This deficit directly impacts the market by limiting the volume of procedures that hospitals can schedule, thereby reducing the daily utilization rates of existing ultrasound equipment. When diagnostic throughput is capped by human resource limitations rather than patient demand, healthcare providers are less incentivized to invest in additional imaging systems, causing procurement departments to delay capital equipment orders.

This workforce crisis is substantiated by recent industry data highlighting the severity of the deficit. According to the Royal College of Radiologists, in 2024, the workforce shortfall for clinical radiology consultants stood at 30%. Such deficits create extended wait times for critical prenatal monitoring and gynecological disorder diagnoses, forcing facilities to prioritize emergency cases over routine screenings. For device manufacturers, this inability to scale services effectively curbs revenue growth, as the installation of new machinery becomes financially difficult to justify without the necessary staff to operate it.

Key Market Trends

The proliferation of handheld and wireless ultrasound technologies is democratizing access to obstetric diagnostics by decoupling imaging from traditional cart-based infrastructure. These compact, battery-operated devices allow clinicians to perform immediate fetal assessments at the bedside or in community clinics, significantly reducing the logistical burden of transporting patients to radiology departments. This shift is being accelerated by semiconductor advancements that now enable pocket-sized probes to deliver image quality comparable to larger consoles, expanding their utility beyond simple screening. For instance, according to Butterfly Network, February 2024, in the 'Butterfly Launches Next-Generation Butterfly iQ3' press release, the company introduced its latest ultrasound-on-chip system which delivers double the data processing speed of its predecessor, effectively bridging the performance gap between portable and high-end fixed systems.

Concurrently, the adoption of tele-ultrasound for remote maternal monitoring is transforming the management of high-risk pregnancies by facilitating clinical oversight outside of hospital settings. This model integrates self-operated ultrasound devices with cloud-based platforms, allowing expectant mothers to capture fetal scans at home that are asynchronously reviewed by clinicians to detect complications early. This approach not only alleviates anxiety for patients but also optimizes clinical resources by minimizing unnecessary in-person visits for routine checks. Demonstrating the scaling of this care model, according to Pulsenmore, July 2024, in the 'July 2024 Pulsenmore Newsletter', the company reported surpassing 120,000 remote ultrasound scans utilizing its home-use technology, highlighting the rapid clinical acceptance of decentralized prenatal surveillance.

Segmental Insights

The Doppler ultrasound segment currently represents the fastest-growing category within the global obstetrics and gynecology ultrasound devices market. This expansion is primarily driven by the critical clinical requirement to assess maternal and fetal hemodynamics during high-risk pregnancies. Unlike standard imaging, Doppler technology enables the precise evaluation of blood flow in the umbilical artery and fetal organs, which is essential for diagnosing conditions such as intrauterine growth restriction and preeclampsia. Increased adherence to clinical guidelines from organizations like the International Society of Ultrasound in Obstetrics and Gynecology regarding fetal surveillance further accelerates the adoption of these diagnostic tools.

Regional Insights

North America maintains a leading position in the Global Obstetrics & Gynecology Ultrasound Devices Market, supported by a robust healthcare infrastructure that enables the widespread utilization of modern imaging technologies. The region’s dominance is driven by an increasing prevalence of gynecological conditions and high-risk pregnancies, necessitating frequent and accurate diagnostic monitoring. Favorable reimbursement coverage for prenatal care and the concentration of major medical device manufacturers further sustain this market leadership. Moreover, the U.S. Food and Drug Administration provides a critical regulatory framework that ensures device safety and efficacy, facilitating the continuous introduction of innovative diagnostic solutions in women's health.

Recent Developments

• In January 2025, Samsung Medison launched the HERA Z20, a premium AI-powered ultrasound system, in the United States market following its debut at a major maternal-fetal medicine meeting. The system was designed to assist with advanced obstetrics and gynecology applications by integrating features such as Live ViewAssist, which automatically classifies cross-sectional images and provides measurements during fetal scans. The company emphasized that this platform aimed to enhance diagnostic accuracy and user convenience for complex cases. The launch highlighted the manufacturer's commitment to introducing next-generation diagnostic tools that support clinician well-being and improve health outcomes for women and fetuses.
• In November 2024, Mindray announced the launch of its Consona-Series ultrasound machines, specifically the Consona N9 and Consona N6, to expand its portfolio for private office settings. These console-based systems were powered by the company's proprietary software-based beamformer, Zone Sonography Technology+ (ZST+), and were engineered to address the specific needs of women's health and radiology departments. The new devices aimed to provide hospital-grade image quality and ergonomic features to office-based practices, facilitating faster exam times and improved workflow. This development represented a strategic move to bridge the gap between hospital and private practice imaging capabilities in the obstetrics and gynecology market.
• In June 2024, Clarius Mobile Health obtained U.S. FDA clearance for its Clarius OB AI fetal biometric measurement tool, a significant development for the handheld ultrasound sector. This AI-powered model was designed to automatically estimate fetal age, weight, and growth intervals, thereby improving access to prenatal monitoring in resource-limited settings. The technology was made available with the company’s wireless handheld scanners and utilized deep learning models trained on over 30,000 fetal images. The company highlighted that this innovation would enable clinicians, including midwives and nurses, to perform consistent and precise fetal ultrasound exams, helping to address the global shortage of trained sonographers.
• In April 2024, GE HealthCare launched the Voluson Signature 20 and 18 ultrasound systems, which were designed to integrate artificial intelligence and advanced tools for the women’s health imaging market. These systems featured the "Hey Voluson" voice command function to reduce keystrokes and the SonoLyst suite, which utilized AI to identify fetal anatomy and automatically annotate standard views. The company stated that these technologies aimed to speed up exam times and provide clearer diagnostic images for clinicians facing high patient volumes. The launch underscored the manufacturer's focus on combining high-performance hardware with scalable software to improve diagnostic confidence in obstetrics and gynecology.

Key Market Players

• GE Healthcare Technologies Inc.
• Siemens Healthcare Private Limited
• Koninklijke Philips N.V.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• FUJIFILM Corporation
• SamsungHealthcare.com
• Esaote SPA
• CANON MEDICAL SYSTEMS CORPORATION
• CHISON Medical Technologies Co., Ltd.

By Portability	By Product	By End Use	By Region
Cart/Trolley-Based Portable/Handheld	2D Ultrasound 3D/4D Ultrasound Doppler Ultrasound	Hospitals Diagnostic Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Obstetrics & Gynecology Ultrasound Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Obstetrics & Gynecology Ultrasound Devices Market, By Portability:

• Cart/Trolley-Based
• Portable/Handheld

• Obstetrics & Gynecology Ultrasound Devices Market, By Product:

• 2D Ultrasound
• 3D/4D Ultrasound
• Doppler Ultrasound

• Obstetrics & Gynecology Ultrasound Devices Market, By End Use:

• Hospitals
• Diagnostic Centers
• Others

• Obstetrics & Gynecology Ultrasound Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE